Kinetic analysis of megakaryopoiesis induced by recombinant human interleukin 11 in myelosuppressed mice

Cytokine

Volumn 13, Issue 5, 2001, Pages 287-294

  Saitoh, Minori ^a   Taguchi, Katsunari ^a   Momose, Kazuhiro ^a   Suga, Kazutaka ^a   Ogawa, Yumiko ^a   Yasuda, Shuhei ^a   Miyata, Keiji ^a  

^a ASTELLAS PHARMA INC   (Japan)

Author keywords

Chemotherapy; Interleukin 11; Megakaryopoietic kinetics; Mice; Thrombocytopenia

Indexed keywords

CYTOKINE; MITOMYCIN C; RECOMBINANT INTERLEUKIN 11;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BONE MARROW SUPPRESSION; CELL MATURATION; CELL PROLIFERATION; DRUG EFFICACY; FEMALE; KINETICS; MEGAKARYOCYTE; MEGAKARYOPOIESIS; MOUSE; NEUTROPENIA; NONHUMAN; PLOIDY; PRIORITY JOURNAL; THROMBOCYTE COUNT; THROMBOCYTOPENIA;

ANIMALIA;

EID: 0035819769     PISSN: 10434666     EISSN: None     Source Type: Journal    
DOI: 10.1006/cyto.2000.0832     Document Type: Article

References (34)

1. Molecular cloning of a cDNA encoding interleukin 11, a stromal cell-derived lymphopoietic and hematopoietic cytokine
2. Synergistic effects of interleukin-3 and interleukin 11 on murine megakaryopoiesis in serum-free culture
3. Interleukin-11 enhances human megakaryocytopoiesis in vitro
4. Synergism between serum factor(s) and erythropoietin in inducing murine megakaryocyte colony formation: The synergistic factor in serum is distinct from interleukin-11 and stem cell factor (c-kit ligand)
5. Recombinant human interleukin-11 directly promotes megakaryocytopoiesis in vitro
6. Recombinant human interleukin-11 synergizes with steel factor and interleukin-3 to promote directly the early stages of murine megakaryocyte development in vitro
7. Leukemia inhibitory factor and interleukin-11 promote maturation of murine and human megakaryocytes in vitro
8. Synergistic effects of stem cell factor and interleukin 6 or interleukin 11 on the expansion of murine hematopoietic progenitors in liquid suspension culture
9. Recombinant human interleukin-11 stimulates megakaryocytopoiesis and increases peripheral platelets in normal and splenectomized mice
10. Thrombopoietic activity of recombinant human interleukin 11 (rHuIL-11) in normal and myelosuppressed nonhuman primates
11. Recombinant human interleukin-11 stimulates multilineage hematopoietic recovery in mice after a myelosuppressive regimen of sublethal irradiation and carboplatin
12. In vivo effects of recombinant interleukin-11 on myelopoiesis in mice
13. Interleukin-11 expression in donor bone marrow cells improves hematological reconstitution in lethally irradiated recipient mice
14. Increased survival and multilineage hematopoietic protection from delayed and severe myelosuppressive effects of a nitrosourea with recombinant interleukin-11
15. Comparative effects of in vivo treatment using interleukin-11 and stem cell factor on reconstitution in mice after bone marrow transplantation
16. A phase I trial of recombinant human interleukin-11 (neumega rhIL-11 growth factor) in women with breast cancer receiving chemotherapy
17. Randomized placebo-controlled study of recombinant human interleukin-11 to prevent chemotherapy-induced thrombocytopenia in patients with breast cancer receiving dose-intensive cyclophosphamide and doxorubicin
18. A randomized placebo-controlled trial of recombinant human interleukin-11 in cancer patients with severe thrombocytopenia due to chemotherapy
19. Effects if rhIL-11 on normal dogs and after sublethal radiation
20. Interleukin-11 stimulates the proliferation of human hematopoietic CD34+ and CD34+CD33-DR- cells and synergizes with stem cell factor, interleukin-3, and granulocyte-macrophage colony-stimulating factor
21. Growth factor requirements for survival in GO and entry into the cell cycle of primitive human hemopoietic progenitors
22. Interleukin-11 stimulates multilineage progenitors, but not stem cells in murine and human long-term marrow cultures
23. Effects of recombinant human interleukin-11 (Neumega rhIL-11 growth factor) on megakaryocytopoiesis in human bone marrow
24. Promotion of megakaryocyte progenitor expansion and differentiation by the c-Mpl ligand thrombopoietin
25. Thrombopoietin: The primary regulator of megakaryocyte and platelet production
26. Effects of pegylated recombinant human megakaryocyte growth and development factor on thrombocytopenia induced by a new myelosuppressive chemotherapy regimen in mice
27. Effects of recombinant interleukin 11 on human megakaryocyte progenitor cells
28. Thrombopoietin (c-mpl ligand) acts synergistically with erythropoietin, stem cell factor, and interleukin-11 to enhance murine megakaryocyte colony growth and increases megakaryocyte ploidy in vitro
29. Megakaryocyte growth and development factor. Analyses of in vitro effects on human megakaryopoiesis and endogenous serum levels during chemotherapy-induced thrombocytopenia
30. A single injection of pegylated murine megakaryocyte growth and development factor (MGDF) into mice is sufficient to produce a profound stimulation of megakaryocyte frequency, size, and ploidization
31. Synergistic interactions between interleukin-11 and interleukin-4 in support of proliferation of primitive hematopoietic progenitors of mice
32. Direct and synergistic effects of interleukin 11 on murine hemopoiesis in culture
33. Measurement of megakaryocyte frequency and ploidy distribution in unfractionated murine bone marrow
34. Thrombopoietin induces megakaryocyte differentiation in hematopoietic progenitor FDC-P2 cells